SeqOnce Biosciences – Expands Their Pathogen Assay Suite with the Addition of RT-qPCR Measles Panel
SeqOnce, a company focused on the research, development, and commercialization of qPCR and NGS genomics tools for the Infectious Disease Research & CLIA Testing Market, has launched their new Measles Panel A. https://mma.prnewswire.com/media/2722343/SeqOnce_email_logo_Logo.jpg “This expansion of our best-in-class RT-qPCR assays for our customers ensures that we can effectively partner throughout their pathogen analysis, from the […]